论文信息 - Primary results of the phase 4 BYOND study of bosutinib (BOS) for pretreated chronic phase (CP) chronic myeloid leukemia (CML). - 字舞流文

Primary results of the phase 4 BYOND study of bosutinib (BOS) for pretreated chronic phase (CP) chronic myeloid leukemia (CML).

U. Olsson‐Strömberg | T. Brümmendorf | G. Rosti | B. Smith | F. Giles | C. Abboud | E. Leip | C. Gambacorti-Passerini | A. Hochhaus | J. Watts | S. Saussele | B. Gjertsen | Pilar Giraldo-Castellano | N. Bardy-Bouxin | A. Viqueira | J. Leone | Byond Study Investigators